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ABSTRACT 
 
Meningococcal disease is an important cause of morbidity and mortality worldwide, 
particularly in children and young adults.  Epidemics caused by Neisseria meningitidis 
continue to plague many countries on a global scale, none more so than countries of the 
African ‘meningitis belt’, where attack rates can reach up to 1000/100,000 population.  It has 
been well recognized that most epidemic and endemic cases of meningococcal disease are 
caused by a limited number of genetically defined clonal groups.  The objective of this 
molecular epidemiological study was to genotypically characterize strains of N. meningitidis 
collected in South Africa from July 1999 to July 2002.  Characterization of meningococcal 
strains belonging to serogroup A, B, C, W135 and Y, by PFGE and MLST allowed us to 
determine the genetic population structure of N. meningitidis in South Africa, and thus identify 
the predominant clonal groups responsible for the majority of meningococcal disease in the 
country over this period.  The results from the genotypic characterization revealed that the 
greatest majority of meningococcal disease in South Africa was caused by a strains belonging 
to only a few “hyperinvasive lineages”, most notably strains of the ST-44 complex (lineage 
III), ST-32 complex (ET-5 complex), ST-11 complex (ET-37 complex), and the ST-1 complex 
(subgroup I/II) which have all been responsible for major epidemics worldwide.  These 
findings have direct implications on public health decision, particularly with regards to the 
development of effective intervention and control strategies, and emphasize the need for 
continuous long-term monitoring of the circulation of these strains in the population. 
 
 
 
 
 
 
 
 
 
 
ii
  
   
 
 
 
 
This dissertation is dedicated to Mom and Dad, who knew just the right combination of kind 
words of encouragement and a kick in the rear to get me through to the end.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii
  
   
ACKNOWLEDGMENTS 
 
• To Dr. Anthony Smith and Dr. Anne von Gottberg at RMPRU - for your guidance and 
assistance throughout my project, and for giving me the space to work and grow 
independently as a scientist.  Many thanks. 
 
• To Prof. Keith Klugman - my sincerest gratitude for your incredible generosity, support 
and inspiration, and for giving me the wonderful once-in-a-lifetime opportunity to go the 
Centers for Disease Control (CDC, Atlanta, USA) and work with some of the best 
scientists around.  It’s an experience I could never forget. 
 
• To Dr. Mignon du Plessis - for always so willingly being available to offer quality advice 
on all matters, both in and out of the laboratory.  And for stocking a legendary sweets 
cupboard too. 
 
• To Mrs. Arvinda Sooka - the sweetest soul on Earth, who almost single-handedly has been 
responsible for keeping my spirits high during my project with her effervescent personality 
and constant encouragement.  You’ve been a Godsend. 
 
• To my Heavenly Father - for heaping so many blessings upon me during the course of my 
studies, and smiling so wonderfully upon all my dreams. 
 
• To the staff at RMPRU: Linda De Gouveia, Thomas Rafundisani, Olga Hattingh and Ruth 
Mpembe  - for so gratefully always being available to assist me as I required.  Your help 
was much appreciated. 
 
• To the Respiratory and Meningeal Pathogens Research Unit, National Health Laboratory 
Service and University of the Witwatersrand for your financial support. 
 
               ……….my sincere gratitude for making this possible. 
 
iv
  
   
PUBLICATION 
 
Coulson, GB, von Gottberg A, Smith A, Klugman K and the National Surveillance Network.  
Investigation of a Community-Based Outbreak of Serogroup C Neisseria meningitidis in South 
Africa (2003). Communicable Disease Surveillance Bulletin, Nov, p.13-16. 
 
 
PRESENTATION 
 
Coulson GB, Whitney A, Klugman K and Popovic T. Genotypic Characterization of Neisseria 
meningitidis in the U.S. and South Africa. 14th International Neisseria Pathogenic Conference, 
September 5-10, 2004. Milwaukee, Wisconsin USA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v
  
   
LIST OF ABBREVIATIONS 
 
>   Greater than 
<   Less than 
%   Percentage 
°C   Degrees Celsius 
ml   Millliliter 
min   Minute 
µl   Microliter 
µM   Micromolar 
secs   Seconds 
et al.   And others 
i.e.   That is 
bp   Base pair 
hrs   Hours 
ATP   Adenosine triphosphate 
CO2   Carbon dioxide 
CSF   Cerebrospinal fluid 
CTAB   Cetyltrimethylammonium bromide 
DNA   Deoxyribonucleic acid 
dNTP   Deoxynucleoside triphosphate 
EDTA   Ethylenediaminetetraacetic acid 
ET   Electropherotypes 
LPS   Lipopolysaccharide 
MgCl2   Magnesium chloride 
MLEE   Multi-locus enzyme electrophoresis 
MLST   Multi-locus sequence typing 
mM   Millimolar 
NHLS   National Health Laboratory Service 
NICD   National Institute for Communicable Diseases 
OMP   Outer membrane protein 
vi
  
   
PCR   Polymerase chain reaction 
PFGE   Pulsed-field gel electrophoresis 
RAPD   Random amplified polymorphic DNA 
RFLP   Restriction fragment length polymorphism 
rpm   Revolutions per minute 
SDS   Sodium dodecyl sulphate 
SS-PCR  Serogroup-specific PCR 
ST   Sequence type 
TAE   Tris-acetate-EDTA 
TBE   Tris-borate-EDTA 
TE   Tris-EDTA 
USA   United States of America 
WHO   World Health Organization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii
  
   
LIST OF FIGURES 
 
Figure 1. Diagrammatic Representation of the Classic Gram-negative Cell 
Envelope………………………………………………………………. 2 
 
Figure 2. Diagrammatic Representation of the Meningitis Belt of sub-Saharan 
Africa………………………………………………………………….. 23 
 
Figure 3. Diagrammatic Representation of South Africa Showing the Provinces  
  and their Respective Population Densities……………………………. 33 
 
Figure 4. PFGE Dendrogram Showing the Genetic Relationship Among  
Serogroup A Meningococci in South Africa July 1999 – July 2002….. 49 
 
Figure 5. PFGE Dendrogram of Serogroup A Meningococci Showing MLST 
Associations…………………………………………………………… 50 
 
Figure 6. PFGE Dendrogram Showing the Genetic Relationship Among  
Serogroup B Meningococci in South Africa July 1999 – July 2002….. 55 
 
Figure 7. PFGE Dendrogram of Serogroup B Meningococci Showing MLST 
Associations…………………………………………………………… 56 
 
Figure 8. PFGE Dendrogram Showing the Genetic Relationship Among 
Serogroup C Meningococci in South Africa July 1999 – July 2002….. 60 
 
Figure 9. PFGE Dendrogram of Serogroup C Meningococci Showing MLST 
Associations…………………………………………………………… 61 
 
 
 
viii
  
   
Figure 10. PFGE Agarose Gel showing the Genetic Relationship between 
Serogroup B and Serogroup C Meningococci of the ST-32/ET-5  
Complex……………………………………………………………….. 62 
 
Figure 11. PFGE Dendrogram Showing the Genetic Relationship Among  
Serogroup W135 Meningococci in South Africa July 1999 – July 2002. 65 
 
Figure 12. PFGE Dendrogram of Serogroup W135 Meningococci Showing  
MLST Associations…………………………………………………… 66 
 
Figure 13. PFGE Dendrogram Showing the Genetic Relationship Among  
Serogroup Y Meningococci in South Africa July 1999 – July 2002….. 70 
 
Figure 14. PFGE Dendrogram of Serogroup Y Meningococci Showing MLST 
Associations…………………………………………………………… 71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix
  
   
LIST OF TABLES 
 
Table 1. Provincial Distribution of Meningococcal Isolates per Serogroup 
 Per Year of Study…………………………………………………….. 43 
 
Table 2. Primer Sequences for Serogroup-Specific PCR………........................ 44 
 
Table 3. MLST PCR Primer Sequences………………………………………… 45 
 
Table 4. MLST Sequencing Primer Sequences………………………………… 46 
 
Table 5. Representative Isolates for MLST – Slide Agglutination and 
SS-PCR Results………………………………………………………. 72 
 
Table 6. MLST Allelic Profiles and Sequence Types (STs)……………………. 73 
 
Table 7. Temporal Variation of the Major Clonal Complexes for Each 
Serogroup……………………………………………………………… 76 
 
Table 8. Geographic Distribution of the Major Clonal Complexes For 
Each Serogroup………………………………………………………… 77 
 
 
 
 
 
 
 
 
 
x
  
   
CONTENTS 
 
 
Declaration...……………………………………………………………………………. i 
Abstract…………………………………………………………………………………. ii 
Dedication.……………………………………………………………………………… iii 
Acknowledgements…………………………………………………………………….. iv 
Publication and Presentation…….……………………………………………...……… v 
List of Abbreviations…………………………………………………………………… vi 
List of Figures…………………………………………………………………...……… viii 
List of Tables…………………………………………………………………………… x 
 
CHAPTER 1:  INTRODUCTION AND LITERATURE REVIEW…………….. 1 
 
1.1 General Background of Neisseria meningitidis……………………………….. 1 
1.1.1 Introduction………………………………………………………… … 1 
1.1.2 History………………………………………………………………… 1 
1.1.3 Organism………………………………………………………………. 2 
1.1.4 Classification…………………………………………………………… 4 
 
1.2 Clinical Features and Pathogenesis of Meningococcal Infection……………... 4 
 1.2.1 Acquisition, Carriage and Transmission………………………………. 4 
 1.2.2 Invasive Disease/Pathology……………………………………………. 6 
 1.2.3 Risk factors for Disease………………………………………………… 8 
 
1.3 Diagnosis and Laboratory Identification……………………………………….. 9 
 1.3.1 Culture Methods………………………………………………………… 9 
 1.3.2 Non-Culture Methods…………………………………………………… 10 
  1.3.2.1 Microscopy and Cell Count……………………………………... 10 
  1.3.2.2 Polysaccharide Antigen Testing………………………………… 10 
  1.3.2.3 Polymerase Chain Reaction……………………………………... 11 
  
   
1.4 Treatment………………………………………………………………………... 12 
 
1.5 Prevention……………………………………………………………………….. 12 
 1.5.1 Chemophrophylaxis……………………………………………………... 12 
 1.5.2 Immunoprophylaxis……………………………………………………... 13 
  1.5.2.1 Introduction……………………………………………………… 13 
  1.5.2.2 Polysaccharide Vaccines………………………………………… 14 
  1.5.2.3 Conjugate Vaccines……………………………………………... 15 
 
1.6 Methods for Typing N. meningitidis………………………………………………. 16 
 1.6.1 Introduction……………………………………………………………… 16 
 1.6.2 Phenotypic Methods……………………………………………………... 17 
  1.6.2.1 Serogrouping and Serotyping…………………………………… 17 
  1.6.2.1 Multi-Locus Enzyme Electrophoresis (MLEE)…………………. 18 
 1.6.3 Genotypic (Molecular) Methods………………………………………… 18 
  1.6.3.1 Ribotyping………………………………………………………. 19 
  1.6.3.2 PCR-Restriction Fragment Length Polymorphism (PCR-RFLP).. 20 
  1.6.3.3 Random Amplified Polymorphic DNA (RAPD)………………... 20 
  1.6.3.4 Pulsed-field Gel Electrophoresis (PFGE)……………………….. 21 
  1.6.3.5 Multi-Locus Sequence Typing (MLST)………………………… 22 
   
1.7 Epidemiology of Neisseria meningitids…………………………………………. 22 
1.7.1 General Introduction…………………………………………………….. 22 
1.7.2 Serogroup A Meningococcal Disease…………………………………… 26 
1.7.3 Serogroup B Meningococcal Disease…………………………………… 27 
1.7.4 Serogroup C Meningococcal Disease…………………………………… 28 
1.7.5 Serogroup W135 Meningococcal Disease………………………………. 29 
1.7.6 Serogroup Y Meningococcal Disease…………………………………… 31 
1.7.7 Meningococcal Epidemiology in South Africa………………………….. 32 
 
1.8 Study Objectives………………………………………………………………… 35 

